The combination of Ang-2/VEGF bispecific antibodies with 5-FU and irinotecan in colorectal cancer or with temozolomide in glioma, showed significant benefits versus the combination of anti-VEGF with chemotherapy [150,151]. The gene discussed is ANGPT2; the disease is glioma.